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Anderson’s disease/chylomicron retention disease
in a Japanese patient with uniparental disomy 7
and a normal SAR1B gene protein coding
sequence
Tomoo Okada1*, Michio Miyashita1, Junji Fukuhara1, Masahiko Sugitani2, Takahiro Ueno3,
Marie-Elisabeth Samson-Bouma4 and Lawrence P Aggerbeck5*
Abstract
Background: Anderson’s Disease (AD)/Chylomicron Retention Disease (CMRD) is a rare hereditary
hypocholesterolemic disorder characterized by a malabsorption syndrome with steatorrhea, failure to thrive and
the absence of chylomicrons and apolipoprotein B48 post-prandially. All patients studied to date exhibit a
mutation in the SAR1B gene, which codes for an essential component of the vesicular coat protein complex II
(COPII) necessary for endoplasmic reticulum to Golgi transport. We describe here a patient with AD/CMRD, a
normal SAR1B gene protein coding sequence and maternal uniparental disomy of chromosome 7 (matUPD7).
Methods and Results: The patient, one of two siblings of a Japanese family, had diarrhea and steatorrhea
beginning at five months of age. There was a white duodenal mucosa upon endoscopy. Light and electron
microscopy showed that the intestinal villi were normal but that they had lipid laden enterocytes containing
accumulations of lipid droplets in the cytoplasm and lipoprotein-size particles in membrane bound structures.
Although there were decreased amounts in plasma of total- and low-density lipoprotein cholesterol,
apolipoproteins AI and B and vitamin E levels, the triglycerides were normal, typical of AD/CMRD. The presence of
low density lipoproteins and apolipoprotein B in the plasma, although in decreased amounts, ruled out
abetalipoproteinemia. The parents were asymptomatic with normal plasma cholesterol levels suggesting a recessive
disorder and ruling out familial hypobetalipoproteinemia. Sequencing of genomic DNA showed that the 8 exons of
the SAR1B gene were normal. Whole genome SNP analysis and karyotyping revealed matUPD7 with a normal
karyotype. In contrast to other cases of AD/CMRD which have shown catch-up growth following vitamin
supplementation and a fat restricted diet, our patient exhibits continued growth delay and other aspects of the
matUPD7 and Silver-Russell Syndrome phenotypes.
Conclusions: This patient with AD/CMRD has a normal SAR1B gene protein coding sequence which suggests that
factors other than the SAR1B protein may be crucial for chylomicron secretion. Further, this patient exhibits
matUPD7 with regions of homozygosity which might be useful for elucidating the molecular basis of the defect(s)
in this individual. The results provide novel insights into the relation between phenotype and genotype in these
diseases and for the mechanisms of secretion in the intestine.
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Background
The differential diagnosis in a young child with diarrhea,
vomiting and failure to thrive accompanied by hypocho-
lesterolemia includes secondary hypocholesterolemias
and the three familial hypocholesterolemias: Hypobetali-
poproteinemia (HBL), Abetalipoproteinemia (ABL) and
Anderson’s Disease (AD)/Chylomicron Retention Dis-
ease (CMRD) [1]. Among the characteristics that distin-
guish these diseases are the complete absence of low
density lipoproteins (LDL) along with very low levels of
plasma triglycerides (TGs) in ABL and homozygous
HBL and low (but not absent) levels of LDL and low
levels of plasma TGs in heterozygous HBL. In contrast,
low (but not absent) levels of plasma LDL and normal
levels of plasma TGs in the patient along with normal
plasma cholesterol values in the parents are indicative of
AD/CMRD.
AD/CMRD (OMIM 246700) is a rare (less than 50
cases described) recessively inherited malabsorption syn-
drome with steatorrhea [1,2]. The small intestine, when
visualized by endoscopy, exhibits a characteristic white
coating. Microscopically, the intestine has normal villi
but the enterocytes are fat-laden and contain large
amounts of large lipid droplets free in the cytoplasm
along with lipoprotein-sized structures in membrane
bound compartments. In the blood, there is a selective
absence of chylomicrons (and of apoB48) in the post-
prandial state and low levels of plasma total lipids, cho-
lesterol, phospholipids, carotenoids, lipid soluble
vitamins (particularly vitamin E), low density (LDL) and
high density (HDL) lipoproteins, apoB, and apoAI.
Of about 50 patients that have been described in the
literature as having AD/CMRD, 34 have mutations (15
different mutations, frameshifts, missense or deletions)
in the SAR1B (formerly SARA2, OMIM 607690) gene
[1] (see also additional file 1 of [2]). Information con-
cerning the SAR1B genes in the other patients has not
been published. The protein product of this gene,
SAR1B, belongs to the Sar1-ADP ribosylation factor
family of small GTPases and plays a critical role in the
vesicular coat protein complex II (COPII)-dependent
transport of proteins from the endoplasmic reticulum to
the Golgi apparatus [3]. All the reported mutations in
the SAR1B gene are predicted to lead to the incapacita-
tion of SAR1B protein function in COPII-dependent
transport and, thus, are expected to result in a defect in
chylomicron secretion.
There are multiple components in the COPII-depen-
dent transport mechanism and recent work has indi-
cated that lipoprotein secretion may be more complex
than previously thought and not involve the components
of the COPII-dependent transport mechanism in a
“classical” way [4,5]. Thus, it might be expected that
mutations in genes other than SAR1B might lead to the
AD/CMRD phenotype.
In this paper, we describe the clinical manifestations and
biochemical characterization of a patient with AD/CMRD
who does not have a mutation in the SAR1B gene protein
coding sequence and who was found also to have maternal
uniparental disomy of chromosome 7 (matUPD7).
Patient and methods
Patient
The patient, a boy born in 2005, was the first of 2 chil-
dren (a sister was born in 2008) of unrelated Japanese
parents. The pregnancy was complicated by hyperten-
sion and oligohydroamnia, and intra-uterine fetal growth
retardation was noted. After 37 weeks and 5 days of
gestation, birth was by uneventful vaginal delivery. The
patient’s birth weight, body length, head circumference
and the chest circumference were all abnormally low
(Table 1). Three days following birth, the patient had
early onset jaundice with induced ABO isoimmunization
which was successfully treated with phototherapy. At
the age of 5 months, fatty, malodorous stools were
noted. The weight gain was extremely poor despite the
intake of 600 - 700 ml formula per day. Total parenteral
nutrition, including essential fatty acids and fat soluble
vitamins, was instituted.
At 9 months of age, the patient was referred to the
Department of Pediatrics of the Nihon University School
of Medicine for failure to thrive and steatorrhea. Physi-
cal examination showed a body weight of 4192 g (-4.79
Standard Deviation Score, SDS) and a body length 59.5
cm (-4.3 SDS). The neurological and opthalmological
examinations were normal.
Laboratory tests (Table 1 and Additional file 1: Addi-
tional blood chemistry values for the patient) showed
decreased levels of plasma total- and LDL-cholesterol
with low normal levels of HDL-cholesterol. In contrast,
the plasma TG level was normal. The plasma apolipo-
protein profile was also altered, with decreased levels of
apoB, apoAI, apoAII and apoE. The levels of vitamin E,
arachidonic acid (20:4 n6) and non-esterified fatty acids
were also low. No acanthocytes were observed. The
value for AST was slightly increased. The growth hor-
mone level, after arginine stimulation, was considered to
be low. After milk feeding, there was no increase in TG
levels as compared to the fasting value and no chylomi-
crons were observed. Typically, in normolipidemic sub-
jects, although a fat load produces no significant change
in total cholesterol concentration, the triglycerides
increase after a fat meal and chylomicrons are easily
demonstrable [6].
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The patient’s father has no significant medical pro-
blems. The patient’s mother is obese (body mass index
= 32.3 kg/m2) and has a fatty liver with hypertriglyceri-
demia, but no other known abnormalities. Both parents
have normal total-, LDL- and HDL-cholesterol levels
(Additional file 2: Blood lipid and other chemistry values
for the parents). Other biochemical parameters for the
parents were normal except for, in the mother only,
slightly increased, apoCII, Lp(a), AST and ALT.
Based upon the clinical and laboratory findings and
current diagnostic criteria [1], a preliminary diagnosis of
AD/CMRD was made for the patient and further studies
were undertaken to confirm the diagnosis.
Methods (see also Additional file 3:
Supplemental methods)
Blood sampling, intestinal biopsies and genetic analyses
were approved by the University Ethics Committee
(Nihon University, Itabashi Hospital). Informed, written
consent was obtained from the parents of the children
and blood samples from the other family members were
obtained following informed consent of the individual.
The study was also performed in the context of a proto-
col approved by INSERM (RBM 0256) and by a
bioethics committee (Comité Consultatif de Protection
des Personnes dans la Recherche Biomédicale de Paris
Bichat-Claude Bernard, Paris, France, CCPPRB Bichat-C.
Bernard-2003/05).
At 19 months of age, jejunal biopsies were obtained
two hours following fat loading (50 g olive oil per 1.73
m2 surface area) via nasal-gastric tube into the stomach
and were examined by light and electron microscopy
according to standard procedures. Venous blood sam-
ples were drawn after a 12-hour fast. Blood lipid, lipo-
protein and apolipoprotein analyses, polyacrylamide gel
electrophoresis and ultracentrifugation were performed
according previously described procedures. Genomic
DNA was isolated from whole blood and the 8 exons of
the SAR1B gene and their flanking intronic sequences
were sequenced by standard methods. Whole genome
SNP analysis and cytogenetic analysis was performed as
described in Additional file 3: Supplemental methods.
Results
Intestinal morphology and ultrastructure
Intestinal video-endoscopy showed a white coating on
the mucosa (Figure 1A). The intestinal biopsy exhibited
normal villi (Figure 1B), however, the enterocytes were
overloaded with fat droplets, that stain with Oil Red O,
mainly at the tip of the villus (Figure 1C). Electron
microscopic examination of the biopsies showed that
the enterocytes contained an accumulation of numerous
free lipid droplets (Figure 1D and Figure 2) as well as
membrane bound lipoprotein-sized structures that accu-
mulated in the cytoplasm of the enterocytes (Figure 2).
SAR1B gene sequencing, whole genome SNP and
karyotype analyses
Sequencing of all 8 exons of the SAR1B gene, including
the intron-exon boundaries revealed no mutations.
Whole genome SNP analysis showed a loss of heterozyg-
osity over extensive regions of chromosome 7 (Additional
file 4: Loss of heterozygosity on chromosome 7). Mater-
nal uniparental disomy (matUPD7) of the entire chromo-
some was found with regions of both isodisomy and
heterodisomy (Figure 3 and Additional file 5: Genotypes
and inferred regions of isodisomy and heterodisomy).
Table 1 Clinical and biological data of the patient.
Parameter Patient
Parental consanguinity No
Age of onset of symptoms 5 months
Growth retardation (at birth)
Weight (SDS) -2.93
Height (SDS) -3.71
Head circumference (SDS) -2.02
Chest circumference (%tile) < 10
Digestive symptoms Diarrhea
Deep tendon reflexes Present, normal
Hematological (Acanthocytes) Absent
Steatorrhea (g/24 hr) 12
Serum lipid (g/L) and vitamin values
Cholesterol (N: 1.2 - 2.2) 1.17, 1.09
LDL-cholesterol (N: 0.60 - 1.30) 0.57, 0.51
HDL-cholesterol (N > 0.40) 0.44, 0.43
Triglycerides (N: 0.27 - 1.20) 1.08, 1.17
ApoAI (N: 1.45+/-0.16) 1.19, 1.27
ApoB (N: 0.75+/-0.14) 0.52, 0.46
ALA (18:3n3) (N: 0.42-1.3 w/w%) 0.66
AA (20:4n6) (N: 4.19-9.57 w/w%) 3.8
EPA (N: 0.54-5.20 w/w%) 0.59
DHA (N: 2.33-7.34 w/w%) 2.32
Vitamin E (N: 7.5-14.1 mg/L) 6.6
Vitamin A (N: 970-3160 IU/L) 1060
AST (xULN)
ALT (x ULN)
1.7
Normal
CK (x ULN) Normal
Endoscopy: white hoary frosting +++
Intestinal biopsy: fat laden enterocytes +++
Ultrastructural analysis
Lipid droplets +++
Membrane bound lipoprotein-like particles +++
Response to oral fat load No chylomicrons
SDS: Standard deviation score, ALA: Alpha linolenic acid; AA: Arachidonic acid;
EPA: Eicosapentaenoic acid; DHA: Docosahexaenoic acid;ULN: Upper limit of
normal; +, ++, +++: present in increasing amounts; AST: Aspartate Amino
Transferase; ALT: Alanine Amino Transferase; CK: Creatine kinase. The values
were obtained at 6-11 months of age.
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Figure 1 Intestinal endoscopy, light and electron microscopy of the intestinal biopsy. Video-endoscopy of the jejunum of patient (A)
shows the typical white coating (« white hoary frosting ») on the small intestinal mucosa, which is not observed in a normal subject. Light
microscopy of the jejunal biopsy stained with hematoxylin/eosin (B) shows vacuolated enterocytes that stain positively with Oil Red O
predominantly at the tips of the villi (C). Goblet cells are normal. Electron microscopy at low magnification of the biopsy shows large lipid
droplets in the cytoplasm as well as smaller lipoprotein-sized particles (D).
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There was a normal 46XY karyotype without any chro-
mosomal abnormalities.
Patient course
At 3 years of age, after having followed a diet restricted
in fat accompanied by vitamin E and essential fatty acid
supplementation and a 60% Medium Chain Triglycer-
ides (MCT) formula, the diarrhea had improved and the
steatorrhea ceased. The growth curve remained below
the normal range for both weight and height (Additional
file 6: Growth curves, growth track and head circumfer-
ence of the patient). There was no micrognathia as
judged by X-ray upon admission and dental develop-
ment has not been delayed although there is a slight
malocclusion and the patient has some difficulty swal-
lowing. The patient has exhibited slow feeding since he
was an infant and he sometimes sweats while asleep.
At 4 years and 10 months of age the patient remained
small in stature and was severely underweight but
the head circumference was within normal limits
(Additional file 6: Growth curves, growth track and
head circumference of the patient). His bone age as
assessed by X-ray (3 years old) was delayed as compared
to his chronological age (4.83 years). His IQ is 81(bor-
derline). He has a slightly triangular face with a small
chin and thin upper lip but without frontal bossing or
low set ears. There is no clino or brachydactyly. No
neurological deficits were found. There are no muscular
symptoms (and in particular no muscular hypotonia).
There are no neuro-ophtalmic or cardiac abnormalities.
The kidneys were normal by ultrasound and computed
tomography. There is no hypospadia or cryptorchidism.
However, the patient had delayed speech with episodes
of asthmatic bronchitis (up to 4 years old) but without
any family history of asthma or allergy. Following vita-
min E supplementation (a-tocopherol 50 mg/kg/d), the
plasma vitamin E level became normal. The total plasma
cholesterol, HDL-cholesterol and LDL-cholesterol
values, however, remained low. The AST level continued
to be slightly increased. Ultrasound revealed a fatty liver.
ヲヰヰﾐﾏ
ヱヰヰﾐﾏ
ヱたﾏ
ヲヰヰﾐﾏ
Figure 2 Electron microscopy of the intestinal biopsy. The enterocytes exhibit large lipid droplets in the cytoplasm. At higher magnification,
numerous lipoprotein-sized particles are apparent which appear to be surrounded by a membrane near a Golgi apparatus which appears
devoid of particles. The intercellular spaces are empty.
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The results are characteristic of AD/CMRD. Several of
the clinical features also recall a Silver-Russell Syndrome
(SRS) or matUPD7 phenotype [7,8] whereas some other
features of SRS or matUPD7 (camptodactyly, joint con-
tractures, café au lait patches, limb asymmetry, muscular
hypotonia, ataxia, dystonia, receptive language impair-
ment, behavioral problems) were specifically evaluated
and found to be absent.
Discussion
Two distinct phenotypes are apparent in this patient;
one consists primarily of the growth and developmental
defects which are characteristic of cases of maternal uni-
parental disomy of chromosome 7 (matUPD7) and the
other is composed of a lipid malabsorption disorder
typical of Anderson’s Disease/Chylomicron retention
disease (AD/CMRD). The mixture of heterodisomy and
isodisomy with isodisomy in the pericentric region sug-
gests trisomy rescue or gamete complementation and a
meiosis II error as a mechanism for the matUPD7 [9].
There does not appear to be a change in copy number.
A trend of advanced mean maternal age in maternal
heterodisomy but not isodisomy has been reported but
the ages of the mother (28 years) and the father (31
years) at the birth of our patient were not particularly
advanced [10,11].
Many of the clinical manifestations that the patient
exhibits and which are found in other cases of what has
been designated as the matUPD7 phenotype are found
also in Silver-Russell Syndrome (SRS): the patient was
small for gestational age (SGA) and exhibited intrauter-
ine (IUGR) and post-natal growth retardation (PNGR),
failure to thrive, speech difficulties, relative macroce-
phaly, and a somewhat triangular face [7,8,12,13].
MatUPD7 is reported to occur in about 5-10% of
patients diagnosed as having SRS, which has been
described as a clinically and genetically heterogeneous
disorder [8]. Other frequently observed features of SRS
7p22
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7p13
7q11.2
7q21.1
7q21.2
7q21.3
7q22
7q31.1
7q31.2
7q31.3
7q32
7q33
7q34
7q35
7q36
7p12
7p11.2
7p11.1
7q11.1
7p21
Homozygosity
Mixed 
Homozygosity/
Heterozygosity
Homozygosity
Mixed 
Homozygosity/
Heterozygosity
Isodisomy
Heterodisomy
Isodisomy
Heterodisomy
SNP ID Position Father Mother Patient
rs1044701 4272360 BB AA                     AA
rs1299548 7268818 BB AB AA
rs1367781 14529570 AA AB BB
rs2030972 16025705 AA AB BB
rs1858941 20603004 BB AA AA
rs766838 25996691 BB AA AA
rs2007664 37990365 BB AA AA
rs1852210 45960781 AA BB BB
rs13222366 55967196 BB AA AA
rs2960920 71721683 AA BB BB
rs2527367 73737074 AA AB BB
rs1023564 88679650 AA AB BB
rs219826 98485075 AA AB BB
rs176481 105515161 BB AB AA
rs885993 116916640 AA AB BB
rs996867 125034557 AA AB BB
rs1582634 134817061 AA AB BB
rs1476640 141058779 AB AB AB
rs700273 145807313 BB AA AA
rs1343750 155214887 AA BB BB
rs455030 158710965 AA AB AB
Figure 3 Maternal uniparental disomy of chromosome 7 (matUPD7). An ideogram of chromosome 7 is shown surrounded, on the right, by
a portion of the genotypes of the patient and his father and mother obtained by SNP analysis and the regions of isodisomy and heterodisomy
that are inferred from the analysis. On the left, regions of complete homozygosity and regions containing both homozygosity and
heterozygosity as determined by SNP analysis are shown. Red boxes show regions of non-Mendelian inheritance.
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are craniofacial anomalies (a small chin with a thin
upper lip, micrognathia, downturned corners of the
mouth and ear anomalies), clinodactyly of the 5th finger
and limb and body asymmetry (present in more than
50% of the patients). Several other features are less con-
stant. The diagnosis of SRS is reported to depend upon
the clinical expertise of the physician and the criteria for
inclusion [8,12,14], however, using the scale proposed
by Bartholdi and colleagues [14], our patient probably
would not be classified as having SRS.
The expressive language impairment that our patient
exhibits resembles the developmental delays (develop-
mental verbal dyspraxia, DVD) that have been found to
be associated with mutations in the FOXP2 gene (Fork-
head-box P2) which is located on chromosome 7 [15].
This gene is located in area of isodisomy, in our patient,
in which both copies of the gene are of maternal origin.
DVD is not a frequent feature in SRS patients but
it is more prevalent in a subgroup of patients with
matUPD7. The dyspraxia phenotype in matUPD7
resembles that found in individuals with FOXP2 dele-
tions but is milder. It has been suggested that the
FOXP2 locus is differentially regulated in a parent-of-
origin specific fashion [15]. The speech and language
phenotype of patients with matUPD7 may be related to
the absence of paternal FOXP2. A further explanation
could be an effect on expression of an imprinted gene
on chromosome 7 involved in the regulation of FOXP2
expression (or one of its isoforms).
The small gestational age (SGA) and intrauterine
growth restriction (IUGR) in our patient could be
related to the pre-eclampsia and oligohydroamnia as
well as to the chromosome abnormality. The level of
growth hormone, following arginine stimulation was
considered to be low. A low level of growth hormone
was reported in the first patient described with
matUPD7 and appears to more common in cases of
maternal heterodisomy as opposed to maternal isodis-
omy of chromosome 7 [7]. The growth delay present
prenatally in maternal UPD7 has been reported to con-
tinue to adulthood [16]. In this respect, it is noteworthy
that, in contrast to other patients with AD/CMRD, our
patient has not shown signs of catch up growth follow-
ing dietary modification and vitamin supplementation
and the height and weight standard deviation score
(SDS) curves remain flat (Additional file 6: Growth
curves, growth track and head circumference of the
patient).
It is not clear whether the defect in chylomicron
secretion (AD/CMRD phenotype) arises due to muta-
tion(s) associated with recessive disease present on chro-
mosome 7 in the heterozygous state in the mother
which become(s) homozygous in our patient due to the
matUPD7 or whether both parents are heterozygous for
the recessive disease mutation on the same or another
chromosome and which has become homozygous in the
patient. This is, however, the first patient with matUPD7
who exhibits a malabsorption phenotype. Each case of
matUPD7 is unique and we conclude that the chromo-
somal regions that are altered in the other matUPD7
patients do not affect any of the genes that are involved
in lipoprotein assembly and secretion. Nevertheless, in
our patient, since matUPD7 leads to regions of chromo-
some 7 which are homozygous for one allele deriving
from the mother which are different from those in other
individuals with matUPD7, there is the possibility for
this being the mechanism leading to the AD/CMRD
phenotype.
All the other patients with AD/CMRD, for which the
gene defect has been established, exhibit mutations in
the SAR1B gene (located on chromosome 5) which are
believed to incapacitate the SAR1B protein in its role in
COPII-dependent transport and result in the defect of
secretion of chylomicrons in the intestine. This is first
description of a patient with AD/CMRD without a
mutation in the protein coding region of the SAR1B
gene. Although our studies do not address the possibi-
lity of a mutation deep within an intron or in the 5’ or
3’ ends of the gene, the relative frequencies of types of
mutations underlying disease phenotypes (data from the
Human Gene Mutation Database, 2011) show that the
majority of mutations in mendelian disorders are mis-
sense or nonsense mutations, affect splice acceptor and
donor sites or correspond to insertions, deletions and
duplications which disrupt coding sequences. Non-cod-
ing or regulatory sequence variants are much less com-
mon and appear to be more likely to have neutral or
weak effects or phenotypes, even in well-conserved non-
coding sequences [17-19]. Nevertheless, local or distant
non-coding genomic elements (promoters, enhancers,
repressors) can play important roles in regulating gene
expression [20] and we cannot rule out a mutation of
this type which might affect, via transcriptional control,
the expression of the SAR1B protein in this patient.
Phenotypes similar to AD/CMRD could arise from
mutations in components other than SAR1B. The tis-
sue-specific pathology in AD/CMRD patients could arise
from mutations in components of paralogue- and cargo-
specific mechanisms of transport analogous to other dis-
eases associated with secretory pathway components
(cranio-lenticulo-sutural dysplasia CLSD [21] and conge-
nital dyserythropoietic anemia type II, CDAII, [22] in
humans and craniorachischisis in mice [23]).
The intestine-specific manifestations in AD/CMRD
might also arise from trafficking pathways for lipopro-
tein secretion that are different in the liver and the
intestine. An intestinal chylomicron-specific transport
mechanism that employs a pre-chylomicron transport
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vesicle (PCTV) has been proposed as an alternative to
the “classical” COPII secretory pathway [4,5] and a
VLDL-specific transport vesicle, the VTV, has been pro-
posed to function in the liver [24,25]. These transport
mechanisms use some elements of the “classical” COPII
coat as well as other protein constituents. This could
explain the few hepatic manifestations in most cases of
AD/CMRD. Futher, additional, specific proteins may
control the loading of very large cargoes by regulating
the size of COPII carriers as, for example TANGO1 and
cTAGE5 in the case of Collagen VII secretion [3,26].
In conclusion, our patient is not unique. In addition to
the family described here, we have now found three
other families having a total of 5 additional affected
individuals that exhibit the AD/CMRD phenotype
(but without matUPD7) for which the protein coding
sequence of the SAR1B gene is normal, as in this
patient. We are currently in the process of defining the
genetic defect(s) in these families.
Conclusions
This is the first report of the AD/CMRD and matUPD7
phenotypes in the same individual. The absence of a
mutation in the SAR1B gene protein coding sequence
suggests that a factor (or factors) other than the SAR1B
protein may play(s) an essential role in chylomicron
secretion. The presence of matUPD7 and the regions of
homozygosity on chromosome 7 might be regions in
which to search for these factors. The results shed new
light on the mechanisms involved in intracellular trans-
port and in the secretion of soluble cargos.
Consent
Informed consent was obtained from each individual
and from the patient’s parents for the participation in
and the publication of this study.
Additional material
Additional file 1: Additional blood chemistry values for the patient.
Additional file 2: Blood lipid and other chemistry values for the
parents.
Additional file 3: Supplemental methods.
Additional file 4: Loss of heterozygosity on chromosome 7.
Extensive regions in which there is a loss of heterozygosity as assessed
by SNP analysis are shown on a diagram of chromosome 7. Large
regions around p22, p21 p12 and q11.2, q21, q22, q31 and q32 have no
B-allele frequencies equal to 0.5.
Additional file 5: Genotypes and inferred regions of isodisomy and
heterodisomy. This file provides the SNP determined genotypes for the
patient, his parents and his sister and regions of isodisomy (green) and
heterodisomy (blue) inferred from the results. In yellow, the genotype of
the sister is identical to the genotype of the brother. Regions in red
indicate non-Mendalian inheritance in the patient as compared to his
father.
Additional file 6: Growth curves, growth track and head
circumference of the patient. The patient has below normal height
and weight and does not show catch up growth. The head
circumference of the patient, which was initially small, became essentially
normal, which when combined with the low weight and size is
consistent with a relative macrocephaly. The standard deviation scores
(SDS) for the patient’s height, weight and head circumference are
plotted as a function of age. There is marked below normal height and
weight with a relatively normal head circumference.
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